Skip to main navigation
Skip to search
Skip to main content
Houston Methodist Scholars Home
Home
Experts
Research units
Cores
Projects
Research output
Prizes
Search by expertise, name or affiliation
Pharmacotherapy versus T lymphocytes for CMV
Helen E. Heslop
Academic Institute
Houston Methodist
Research output
:
Contribution to journal
›
Comment/debate
›
peer-review
2
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Pharmacotherapy versus T lymphocytes for CMV'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
T Cells
100%
Pharmacotherapy
100%
Cytomegalovirus
100%
Cytotoxic T Cells
100%
Phase II Study
50%
Allogeneic Hematopoietic Stem Cell Transplant Recipients
50%
Medicine and Dentistry
Drug Therapy
100%
Cytomegalovirus
100%
T Lymphocyte
100%
Cytotoxic T-Cell
100%
Hematopoietic Stem Cell Transplantation
50%